In November 2022, the National Institute for Health Research (NIHR) in England released one MedTech-related report in its Health Technology Assessment (HTA) Journal, which concerned SeHCAT (radiopharmaceutical) for the investigation of bile acid diarrhea. HTA Journal publishes research reports on the effectiveness, costs, and broader impact of health technologies for those who use, manage, and provide care in the NHS and informs National Institute for Health and Care Excellence (NICE) guidance.